10 Stocks Drowned Heavily. Are You Holding Any?

6. Oscar Health, Inc. (NYSE:OSCR)

Oscar Health declined by 12.7 percent week-on-week as investor sentiment was dampened anew by another rating downgrade for its stock.

Last week, Wells Fargo lowered its stock rating and price target for Oscar Health, Inc. (NYSE:OSCR) to “underweight” from “equal weight” and to $10 from $16 previously, amid concerns about rising medical costs and inadequate pricing for 2025. The new price marked a 30.4-percent downside from its latest closing price of $14.38.

This followed Barclays’ first coverage of Oscar Health, Inc. (NYSE:OSCR) on July 2, assigning the firm with an “underweight” rating but with a price target higher than Wells Fargo’s, of $17 apiece.

According to Barclays, its coverage reflected policy risks that could derail the insurer’s ambitious margin and growth targets.

It can be recalled that Oscar Health, Inc. (NYSE:OSCR), under new leadership, set a goal of more than $2.25 earnings per share by 2027.